The University of Southampton
University of Southampton Institutional Repository

Proteomic analysis of amniotic fluid in pregnancies with Down syndrome

Proteomic analysis of amniotic fluid in pregnancies with Down syndrome
Proteomic analysis of amniotic fluid in pregnancies with Down syndrome
Proteomic analysis is widely used for the detection of diagnostic markers. In the present study amniotic fluid supernatants?(AFS) from pregnancies with Down syndrome?(DS) fetuses and from chromosomally normal fetuses in the 17th?week of gestation were analyzed by 2-DE. Gel comparison revealed significant differences in the two groups. Spots with different expression levels were excised and proteins were identified by MALDI-MS and nano-ESI-MS/MS. Splicing factor arginine/serine-rich?4 (SFRS4; Q08170) was present only in AFS from DS fetuses and completely absent in the control group. Quantitative differences were detected for alpha-1-microglobulin (AMBP; P02760), collagen alpha?1?(I) chain (CO1A1; P02452), collagen alpha?1?(III) chain (CO3A1; P02461), collagen alpha?1?(V) chain?d (CO5A1; P20908), and basement membrane-specific heparin sulfate proteoglycan core protein (PGBM; P98160). These proteins were increased in cases with DS, whereas protein?IBP-1 (P08833) was decreased by 40% compared with chromosomally normal fetuses. Four proteins, CO1A1, CO3A1, CO5A1, and PGBM, appeared as fragments. As differentially expressed proteins were present in all pregnancies with DS tested, they may represent useful potential markers for prenatal diagnosis. However, for protein biomarkers to be of any clinical utility, systematic analysis of the maternal serum should be conducted.
1615-9853
4410-4419
Tsangaris, George Th.
9271b5ad-7a60-4e90-89f4-88ed0e1de520
Karamessinis, Panagiotis
e79360a4-cd88-46b2-9a52-a647e20ad74a
Kolialexi, Aggeliki
bac99d0b-b2e9-4062-95e6-632dff27d71d
Garbis, Spiros D.
7067fd19-50c9-4d42-9611-f370289470bd
Antsaklis, Aris
86c86f67-e9e9-4eb5-8a29-2afde8e4e5d0
Mavrou, Ariadni
60eaf02e-06bf-4258-878d-b024f555a508
Fountoulakis, Michael
7918e434-8d49-49da-bd7e-45f71b6401b8
Tsangaris, George Th.
9271b5ad-7a60-4e90-89f4-88ed0e1de520
Karamessinis, Panagiotis
e79360a4-cd88-46b2-9a52-a647e20ad74a
Kolialexi, Aggeliki
bac99d0b-b2e9-4062-95e6-632dff27d71d
Garbis, Spiros D.
7067fd19-50c9-4d42-9611-f370289470bd
Antsaklis, Aris
86c86f67-e9e9-4eb5-8a29-2afde8e4e5d0
Mavrou, Ariadni
60eaf02e-06bf-4258-878d-b024f555a508
Fountoulakis, Michael
7918e434-8d49-49da-bd7e-45f71b6401b8

Tsangaris, George Th., Karamessinis, Panagiotis, Kolialexi, Aggeliki, Garbis, Spiros D., Antsaklis, Aris, Mavrou, Ariadni and Fountoulakis, Michael (2006) Proteomic analysis of amniotic fluid in pregnancies with Down syndrome. Proteomics, 6 (15), 4410-4419. (doi:10.1002/pmic.200600085). (PMID:16847874)

Record type: Article

Abstract

Proteomic analysis is widely used for the detection of diagnostic markers. In the present study amniotic fluid supernatants?(AFS) from pregnancies with Down syndrome?(DS) fetuses and from chromosomally normal fetuses in the 17th?week of gestation were analyzed by 2-DE. Gel comparison revealed significant differences in the two groups. Spots with different expression levels were excised and proteins were identified by MALDI-MS and nano-ESI-MS/MS. Splicing factor arginine/serine-rich?4 (SFRS4; Q08170) was present only in AFS from DS fetuses and completely absent in the control group. Quantitative differences were detected for alpha-1-microglobulin (AMBP; P02760), collagen alpha?1?(I) chain (CO1A1; P02452), collagen alpha?1?(III) chain (CO3A1; P02461), collagen alpha?1?(V) chain?d (CO5A1; P20908), and basement membrane-specific heparin sulfate proteoglycan core protein (PGBM; P98160). These proteins were increased in cases with DS, whereas protein?IBP-1 (P08833) was decreased by 40% compared with chromosomally normal fetuses. Four proteins, CO1A1, CO3A1, CO5A1, and PGBM, appeared as fragments. As differentially expressed proteins were present in all pregnancies with DS tested, they may represent useful potential markers for prenatal diagnosis. However, for protein biomarkers to be of any clinical utility, systematic analysis of the maternal serum should be conducted.

Text
Proteomic analysis of amniotic fluid in pregnancies with Down syndrome.pdf - Version of Record
Restricted to Repository staff only
Request a copy

More information

Published date: August 2006
Organisations: Cancer Sciences

Identifiers

Local EPrints ID: 395428
URI: http://eprints.soton.ac.uk/id/eprint/395428
ISSN: 1615-9853
PURE UUID: 5757d8b2-99af-4382-9e5a-c5e5ddcd39b3
ORCID for Spiros D. Garbis: ORCID iD orcid.org/0000-0002-1050-0805

Catalogue record

Date deposited: 18 Jul 2016 11:02
Last modified: 15 Mar 2024 00:40

Export record

Altmetrics

Contributors

Author: George Th. Tsangaris
Author: Panagiotis Karamessinis
Author: Aggeliki Kolialexi
Author: Spiros D. Garbis ORCID iD
Author: Aris Antsaklis
Author: Ariadni Mavrou
Author: Michael Fountoulakis

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×